Sanofi (TSX:SNY)
19.27
+0.11 (0.57%)
Oct 26, 2026, 1:58 PM EDT
Sanofi Employees
Sanofi had 74,846 employees as of December 31, 2025. The number of employees decreased by 8,032 or 9.69% compared to the previous year.
Employees
74,846
Change (1Y)
-8,032
Growth (1Y)
-9.69%
Revenue / Employee
1.06M CAD
Profits / Employee
85.80K CAD
Market Cap
140.09B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 74,846 | -8,032 | -9.69% |
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
| Cronos Group | 610 |
Sanofi News
- 3 days ago - These French Companies Have Global Reach. The Stocks Are Bargains. - Barrons
- 5 days ago - Teva/Sanofi: Duvakitug Maintains Meaningful Efficacy Improvements In Long-term Extension Study - Finanz Nachrichten
- 6 days ago - Teva: Duvakitug Maintains Meaningful Efficacy Improvements In Long-term Extension Study - Finanz Nachrichten
- 6 days ago - Is It Too Late to Buy Sanofi SA (SNY) After 4.6% Rally? GF Value Says Undervalued - GuruFocus
- 6 days ago - Teva, Sanofi Report Sustained Duvakitug Benefits In Phase 2b IBD Study - Nasdaq
- 6 days ago - Sanofi, ScionxBio enter collaboration, licensing agreement - TheFly
- 6 days ago - ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics - Business Wire
- 6 days ago - Teva Pharmaceutical Industries Ltd: UEG Week: Teva and Sanofi's Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn's Disease - Finanz Nachrichten